Urinary calculi

Urinary calculi, commonly referred to as kidney or bladder stones, are solid accretions of minerals and acid salts that precipitate out of solution in the urine and aggregate within the urinary tract (StatPearls, 2023). They are classified as a disease state or pathological finding rather than a therapeutic molecular target such as a receptor or enzyme (NIH, 2023). The most common compositions include calcium oxalate, calcium phosphate, uric acid, struvite, and cystine. While various pharmacological agents are used to prevent or facilitate the passage of stones, these drugs act on specific molecular targets—such as the sodium-chloride symporter or xanthine oxidase—to alter urine chemistry, rather than binding to the calculi themselves as a primary target (Mayo Clinic, 2024). Therefore, urinary calculi represent the clinical manifestation of underlying metabolic disturbances or anatomical issues. Because they are inorganic or organic crystal masses and not biological signaling molecules, they do not possess a molecular classification or intrinsic biological function.

Other names

Kidney stoneNephrolithiasisUrolithiasisRenal calculusBladder stoneCystolithiasis

Not applicable. Urinary calculi are pathological mineral deposits and do not function as molecular targets. Pharmacological treatments target metabolic enzymes (e.g., xanthine oxidase) or ion transporters (e.g., sodium-chloride symporter) to modify the urinary environment and prevent stone formation (StatPearls, 2023).